Linde plc
NASDAQ:LINChemicals - Specialty
-$0.89 today
- Market cap
- $235.12B
- Beta
- 0.73
- P/E (TTM)
- 33.5
- EPS (TTM)
- $15.35
- Dividend yield
- 1.20%
Volume 1.37M
Average 2.28M
LIN Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Linde plcNASDAQ: LIN
Total Equity · Q2 FY2026 · quarter ended Jun 2026
Total equity broadly unchanged from a year ago
Total equity stood at $40.62B at the end of Q2 FY2026, up 1.6% from a year earlier and up 1.3% from the prior quarter. Over 3 fiscal years it compounded at -1.3% a year.
Context
- Total equity amounted to 46.0% of total assets at the end of Q2 FY2026, down 0.5 pp from a year earlier.
- Total equity increased in 1 of the last 3 fiscal years.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +1.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 39.74B USD
- Year-over-year change
- +0.6%
- 4-year CAGR
- -3.3%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 39.74B | +0.6% |
| FY2024 | 2024-12-31 | 39.49B | -3.9% |
| FY2023 | 2023-12-31 | 41.1B | -0.7% |
| FY2022 | 2022-12-31 | 41.39B | -8.9% |
| FY2021 | 2021-12-31 | 45.44B | — |
Total Equity vs competitors
How LIN compares with its peers on the latest reported figures
- LIN's Jun 2026 total equity of $40.62B is the highest of the 2 companies compared; the peer median is $20.02B.
- Its year-over-year change of +1.6% is the lowest of 2, against a peer median of +15.4%.
- Total equity amounts to 46.0% of total assets for LIN, versus a peer median of 48.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $40.62B | +1.6% | -1.3% | 46.0% | |
| Sep 2026 | $20.02B | +15.4% | +8.2% | 48.6% | |
| Peer median (excluding LIN) | $20.02B | +15.4% | +8.2% | 48.6% | |
Competitors are the stored peer set for LIN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.82B | 5.44B | 4.66B | 4.85B | 5.06B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 4.83B | 4.91B | 5.09B | 5.06B | 5.24B |
| Inventory | 1.73B | 1.98B | 2.12B | 1.95B | 2.06B |
| Other Current Assets | 247M | 128M | 166M | 508M | 979M |
| Total Current Assets | 10.16B | 13.05B | 12.62B | 12.95B | 13.33B |
| Property, Plant & Equipment (Net) | 26B | 23.55B | 25.49B | 25.76B | 29.34B |
| Goodwill | 27.04B | 25.82B | 26.75B | 25.94B | 27.93B |
| Intangible Assets | 13.8B | 12.42B | 12.4B | 11.33B | 11.87B |
| Long-term Investments | 2.64B | 2.53B | 2.38B | 2.24B | 2.12B |
| Tax Assets | 242M | 230M | 226M | 0 | 423M |
| Other Non-current Assets | 1.72B | 2.06B | 948M | 1.94B | 1.81B |
| Total Non-current Assets | 71.45B | 66.61B | 68.19B | 67.2B | 73.49B |
| Total Assets | 81.61B | 79.66B | 80.81B | 80.15B | 86.82B |
| Account Payables | 3.5B | 3B | 3.02B | 2.51B | 2.81B |
| Short-term Debt | 2.87B | 5.72B | 5.98B | 6.28B | 6.31B |
| Tax Payables | 724M | 872M | 917M | 0 | 0 |
| Deferred Revenue | 2.94B | 3.07B | 1.9B | 1.19B | 1.23B |
| Other Current Liabilities | 2.89B | 3.19B | 3.22B | 1.27B | 4.85B |
| Total Current Liabilities | 13.64B | 16.48B | 15.72B | 14.54B | 15.2B |
| Long-term Debt | 11.34B | 12.2B | 13.4B | 15.34B | 20.68B |
| Deferred Tax Liabilities | (7B) | 0 | 5.75B | 0 | 0 |
| Deferred Revenue (Non-current) | 7B | 0 | 1.05B | 0 | 0 |
| Other Non-current Liabilities | 10.44B | 8.94B | 3.09B | 10.02B | 11.2B |
| Total Non-current Liabilities | 22.52B | 21.79B | 24B | 26.12B | 31.88B |
| Total Liabilities | 36.16B | 38.27B | 39.72B | 40.66B | 47.08B |
| Common Stock | 1M | 1M | 1M | 1M | 1M |
| Retained Earnings | 18.71B | 20.54B | 8.85B | 12.63B | 16.61B |
| Accumulated OCI | (5.05B) | (5.78B) | (5.81B) | (6.89B) | (6.23B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1.41B | 1.36B | 1.38B | 1.4B | 1.5B |
| Total Equity | 45.44B | 41.39B | 41.1B | 39.49B | 39.74B |
| Total Debt | 15.22B | 18.79B | 20.32B | 22.61B | 26.99B |
| Net Debt | 12.39B | 13.36B | 15.65B | 17.76B | 21.93B |
Linde plc
NASDAQ:LIN
Intrinsic Alpha fair value
Locked
Current Price
$512.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.